[PHOTOS] CIRM’s Bridges to Stem Cell Research Program hosts annual conference in sunny San Diego

For more than a decade, the California Institute for Regenerative Medicine (CIRM) has funded educational and research training programs to give students the opportunity to explore regenerative medicine and stem cell science right here in California.   

This summer, the CIRM team was thrilled to meet the bright scientists taking part in this year’s Bridges to Stem Cell Research Program, which culminated at the 2022 Bridges Trainee Meeting in sunny San Diego.  

Started in 2009, the Bridges program provides paid stem cell research internships to students at universities and colleges that don’t have major stem cell research programs. Each Bridges internship includes thorough hands-on training and education in regenerative medicine and stem cell research, and direct patient engagement and outreach activities that engage California’s diverse communities. 

To date, there are 1,663 Bridges alumni, and another 109 Bridges trainees are completing their internships in 2022. 

In addition to networking with other scientists across the state, the annual Bridges Trainee Meeting provides students the opportunity to share their research in poster presentations and to learn about careers in the regenerative medicine field. This year, students also attended talks about cutting edge science research, anti-racism in STEM, science communication through social media, and patient advocacy.  

“As the field advances, we must also meet the demand for promising young scientists,” says Maria T. Millan, M.D., President and CEO of CIRM (pictured below). “The CIRM Bridges programs across the state of California will provide students with the tools and resources to begin their careers in regenerative medicine.” 

There are currently 15 active Bridges programs throughout California, each with its own eligibility criteria and application process. If you are interested in applying, please visit this web page for more details about each program. If you have questions about the Bridges program, please email the CIRM Bridges director, Dr. Kelly Shepard at education@cirm.ca.gov. 

Finally, a sincere thank you goes to the Bridges Program from California State University, San Marcos for hosting this year’s CIRM Bridges Trainee Meeting! 

Check out some of the photos from this year’s conference below.

CIRM Board gives thumbs up to training and treatment programs

THIS BLOG IS ALSO AVAILABLE AS AN AUDIO CAST

CIRM Bridges student discusses her poster presentation

At CIRM, the bread and butter of what we do is funding research and hopefully advancing therapies to patients. But the jam, that’s our education programs. Helping train the next generation of stem cell and gene therapy scientists is really inspiring. Watching these young students – and some are just high school juniors – come in and grasp the science and quickly become fluent in talking about it and creating their own experiments shows the future is in good hands.

Right now we fund several programs, such as our SPARK and Bridges internships, but they can’t cover everything, so last week the CIRM Board approved a new training program called COMPASS (Creating Opportunities through Mentorship and Partnership Across Stem Cell Science). The program will fill a critical need for skilled research practitioners who understand and contribute at all levels in the translation of science to medicine, from bench to bedside.

The objective of the COMPASS Training Program is to prepare a diverse group of undergraduate students for careers in regenerative medicine through the creation of novel recruitment and support mechanisms that identify and foster untapped talent within populations that are historically under-represented in the biomedical sciences. It will combine hands-on research with mentorship experiences to enhance transition of students to successful careers. A parallel objective is to foster greater awareness and appreciation of diversity, equity and inclusion in trainees, mentors, and other program participants

The CIRM Board approved investing $58.22 million for up to 20 applications for a five-year duration.

“This new program highlights our growing commitment to creating a diverse workforce, one that taps into communities that have been historically under-represented in the biomedical sciences,” says Dr. Maria T. Millan, President and CEO of CIRM. “The COVID19 pandemic made it clear that the benefits of scientific discovery are not always accessible to communities that most need them. CIRM is committed to tackling these challenges by creating a diverse and dedicated workforce that can meet the technical demands of taking novel treatment ideas and making them a reality.”

The Board also approved a new $80 million concept plan to expand the CIRM Alpha Stem Cell Clinic Network. The Network clinics are all in top California medical centers that have the experience and the expertise to deliver high-quality FDA-authorized stem cell clinical trials to patients.

There are currently five Alpha Clinics – UC San Diego; UCLA/UC Irvine; City of Hope; UCSF; UC Davis – and since 2015 they have hosted more than 105 clinical trials, enrolled more than 750 patients in these trials, and generated more than $95 million in industry contracts. 

Each award will provide up to $8 million in funding over a five-year period. The clinics will have to include:

  • A demonstrated ability to offer stem cell and gene therapies to patients as part of a clinical trial.
  • Programs to help support the career development of doctors, nurses, researchers or other medical professionals essential for regenerative medicine clinical trials.
  • A commitment to data sharing and meeting CIRM’s requirements addressing issues of diversity, equity and inclusion and meeting the needs of California’s diverse patient population.